ACCESSION: MSBNK-SMB_Measured-HSA015P0087009
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 11
COMMENT: RAW_SPEC {'EL24_pos_1489': {'bp': 1083528.0, 'sum': 1529350.0}, 'EL16_pos_1483': {'bp': 1071376.0, 'sum': 1435170.0}, 'EL03_pos_1549': {'bp': 901073.0, 'sum': 1550202.0}, 'EL06_pos_1483': {'bp': 836166.0, 'sum': 1256185.0}, 'EL09_pos_1489': {'bp': 614025.0, 'sum': 1167584.0}, 'EL05_pos_1489': {'bp': 604787.0, 'sum': 1168040.0}, 'EL19_pos_1495': {'bp': 503483.0, 'sum': 1097488.0}, 'EL04_pos_1495': {'bp': 498099.0, 'sum': 1204991.0}, 'EL07_pos_1489': {'bp': 425301.0, 'sum': 1102290.0}, 'EL21_pos_1451': {'bp': 261350.0, 'sum': 629730.0}, 'EL14_pos_1457': {'bp': 253769.0, 'sum': 644589.0}}
COMMENT: RETENTION_TIME_STDEV 0.027
COMMENT: PRECURSOR_M/Z_RAW 87.092334
COMMENT: PRECURSOR_M/Z_STDEV 0.000026
COMMENT: PRECURSOR_IN_MS1 mz 87.091654; int 385.391; delta(ppm) 0.249355
COMMENT: PROPOSED_CHARGE_STATE +1; mz 88.095014; int 16.405; cor 0.955
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.012; C4H10N2; [M+H]+; delta(ppm) -0.011617
COMMENT: PROPOSED_MF MS-FINDER 3.162; C4H10N2; [M+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.992; C4H10N2; [M+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H10N2; [M+H]+; delta(ppm) -0.020274
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 3.000; GLUUGHFHXGJENI-UHFFFAOYSA-N; C4H10N2; Massbank:KO003733 PiperazineDiethylenediamine
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.500; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+H]+; C1CCN(C1)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.472; DKYBVKMIZODYKL-UHFFFAOYSA-N; [M+H]+; C1CNCNC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.450; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+H]+; C1CNCCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.450; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+H]+; C1CNCC1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.417; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+H]+; CCCC(N)=N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.266; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+H]+; Piperazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.849; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+H]+; Butanimidamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.797; ACPWGAXCVWNYSW-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,1-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.797; DKYBVKMIZODYKL-UHFFFAOYSA-N; [M+H]+; 1,3-diazinane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.797; FPYGTMVTDDBHRP-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.797; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.797; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.797; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+H]+; Piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+H]+; Butanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ACPWGAXCVWNYSW-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,1-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; DKYBVKMIZODYKL-UHFFFAOYSA-N; [M+H]+; 1,3-diazinane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FPYGTMVTDDBHRP-UHFFFAOYSA-N; [M+H]+; but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; GLUUGHFHXGJENI-UHFFFAOYSA-N; [M+H]+; piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.454; SBMSLRMNBSMKQC-UHFFFAOYSA-N; [M+H]+; pyrrolidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.402; NGXSWUFDCSEIOO-UHFFFAOYSA-N; [M+H]+; pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.279; RXKUYBRRTKRGME-UHFFFAOYSA-N; [M+H]+; butanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.257; INTMMHZKGCDQGT-UHFFFAOYSA-N; [M+H]+; diethyldiazene
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.237; HTFFABIIOAKIBH-UHFFFAOYSA-N; [M+H]+; diazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.223; NDAJNMAAXXIADY-UHFFFAOYSA-N; [M+H]+; 2-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.167; HQFQTTNMBUPQAY-UHFFFAOYSA-N; [M+H]+; cyclobutylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.137; PAXRVGDTBDATMF-UHFFFAOYSA-N; [M+H]+; N,N-dimethylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.133; BIWZYRJXBPPLLA-UHFFFAOYSA-N; [M+H]+; 1-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.133; UYLSVYARXBFEKV-UHFFFAOYSA-N; [M+H]+; cyclobutane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.132; JMHYNOCZNRXMLN-UHFFFAOYSA-N; [M+H]+; N,N'-dimethylethanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.131; FPYGTMVTDDBHRP-OWOJBTEDSA-N; [M+H]+; (E)-but-2-ene-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.129; SVKQJKDFMLYPSM-UHFFFAOYSA-N; [M+H]+; N'-methylpropanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.129; MLTKZVHOZAKJMV-UHFFFAOYSA-N; [M+H]+; 3-ethyl-3-methyldiaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.128; FBFGFCAGFFHMPG-UHFFFAOYSA-N; [M+H]+; cyclopropylmethylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.128; NQPTWMKTGPWPMX-UHFFFAOYSA-N; [M+H]+; N-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.128; VMAXJDJIFGIBGH-UHFFFAOYSA-N; [M+H]+; azetidin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.128; FDWQPDLACZBQBC-PLNGDYQASA-N; [M+H]+; N-[(Z)-ethylideneamino]-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.127; MRYNEEIGLSDRKH-UHFFFAOYSA-N; [M+H]+; azetidin-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.127; JATTWGKYNBEIMH-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; PYBBRDLRXFWWFU-UHFFFAOYSA-N; [M+H]+; 3-methylazetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; SPPFMFXKGYNRER-UHFFFAOYSA-N; [M+H]+; 4-methylpyrazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; PRCGMIFKQRXNBS-UHFFFAOYSA-N; [M+H]+; 2-methylidenepropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; JYQKJYDDOGBPOA-UHFFFAOYSA-N; [M+H]+; 1-cyclopropyl-1-methylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; HBRZQKXSEKTPEW-UHFFFAOYSA-N; [M+H]+; but-3-enylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; WKWPTGYQIHKPSJ-UHFFFAOYSA-N; [M+H]+; 2-methylprop-2-enylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; VHCQWQAYVBRQQC-ZXZARUISSA-N; [M+H]+; (1R,2S)-cyclobutane-1,2-diamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H11N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.389
MS$FOCUSED_ION: PRECURSOR_M/Z 87.091673
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9000000000-b74cc1731b0de4098f58
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0496940 31.1936 56.050406 0.9813 29.76 -0.2619 8 f{C3H6N1}/3.90ppm,p-C1H5N1
  56.9650220 15.5982 56.965738 0.9655 6.37 0.3697 10 ?
  57.0336950 11.8171 57.034411 1.3325 5.69 0.4762 8 ?
  58.0653833 28.8808 58.066104 1.1883 13.14 -0.0455 11 f{C3H8N1}/4.44ppm,p-C1H3N1
  59.0493787 16.5179 59.050103 0.6943 7.13 0.6190 8 ?
  68.9822992 15.2335 68.983042 1.1452 2.48 0.9667 9 ?
  69.0335820 15.6607 69.034325 1.6803 6.27 0.6364 10 ?
  69.0700245 15.7095 69.070768 1.1293 8.42 -0.2857 8 ?
  70.0652758 71.8068 70.066019 0.5566 42.19 -0.5000 11 f{C4H8N1}/2.14ppm,p-H3N1
  71.0128788 23.7192 71.013622 0.7604 9.38 0.8303 10 ?
  72.9982121 17.6229 72.998954 0.7534 8.37 0.2833 9 ?
  84.9597509 16.7071 84.960463 1.4007 4.30 0.7000 11 ?
  85.0284358 29.9994 85.029147 1.0114 15.46 -0.0818 11 ?
  86.0236857 24.7006 86.024393 1.0578 11.39 0.4636 11 ?
  86.0600677 66.6661 86.060774 0.8715 30.66 0.2000 11 ?
  86.0964604 22.6122 86.097167 0.9989 13.74 -0.3091 10 ?
  87.0440815 66.4553 87.044784 1.0340 30.50 0.1091 11 ?
  87.0552790 20.6206 87.055981 1.0338 8.49 0.7091 10 ?
  87.0917091 999.0000 87.092411 0.2641 0.00 1.0000 11 f{C4H11N2}/0.39ppm,p
  88.0215520 59.3337 88.022249 0.5908 30.14 -0.2182 11 ?
  88.0757514 91.0946 88.076448 0.6926 50.26 0.0909 11 ?
  88.0949513 37.9822 88.095648 1.1124 5.42 0.9636 10 ?
PK$NUM_PEAK: 22
PK$PEAK: m/z int. rel.int.
  56.049694 31.19 31
  56.965022 15.60 15
  57.033695 11.82 11
  58.065383 28.88 28
  59.049379 16.52 16
  68.982299 15.23 15
  69.033582 15.66 15
  69.070025 15.71 15
  70.065276 71.81 71
  71.012879 23.72 23
  72.998212 17.62 17
  84.959751 16.71 16
  85.028436 30.00 29
  86.023686 24.70 24
  86.060068 66.67 66
  86.096460 22.61 22
  87.044082 66.46 66
  87.055279 20.62 20
  87.091709 999.00 999
  88.021552 59.33 59
  88.075751 91.09 91
  88.094951 37.98 37
//
